KMTS

Kestra Medical Technologies Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth 2/10
  • Value 0/10
Kestra Medical Technologies sales and earnings growth
KMTS Growth
Fair
  • Revenue Y/Y 59.06%
  • EPS Y/Y 30.54%
  • FCF Y/Y -35.51%
Kestra Medical Technologies gross and profit margin trends
KMTS Profitability
Neutral
  • Gross margin 48.80%
  • EPS margin -176.90%
  • ROIC 5Y 0.00%
Kestra Medical Technologies net debt vs free cash flow
KMTS Risk
Great
  • Debt / Equity 0.2
  • Debt / FCF 0.0
  • Interest coverage -18.3

Kestra Medical Technologies stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗